In fact, there is increasing evidence of altered lipid metabolism in cc-RCC including aberrant expression of fatty acid synthase, steroyl-CoA desaturase 1 (SCD1), A:cholesterol acyl transferase, glucosylceramide synthase and several other lipogenic genes [13–15]. This evidence concerns the gene FASN and renal cell carcinoma.